The impact of T-cell depletion on the effects of HLA DRβ1 and DQβ allele matching in HLA serologically identical unrelated donor bone marrow transplantation

Biology of Blood and Marrow Transplantation

Volumn 3, Issue 2, 1997, Pages 76-82

  Gajewski, James ^a   Gjertson, David ^b   Cecka, Michael ^b   Tonai, Richard ^b   Przepiorka, Donna ^a   Hunt, Lynne ^b   Giralt, Sergio ^a   Chan, Ka Wah ^a   Feig, Stephen ^b   Territo, Mary ^b   Andersson, Borje ^a   Van Besien, Koen ^a   Khouri, Issa ^a   Fischer, Harald ^a   Babbitt, Lynn ^b   Ippolitti, Cindy ^a   Schiller, Gary ^b   Lill, Michael ^b   Warkentin, Dawn ^a   Neumann, Joyce ^a   Petz, Lawrence ^b   Terasaki, Paul ^b   Champlin, Richard ^a   more..

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

HLA DQ; HLA DR 1; Unrelated donor bone marrow transplants

Indexed keywords

HLA DQ ANTIGEN; HLA DR ANTIGEN;

ADULT; ALLELE; ARTICLE; BONE MARROW TRANSPLANTATION; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CYTOLOGY; DONOR; FEMALE; GENETICS; GRAFT VERSUS HOST REACTION; HISTOCOMPATIBILITY TEST; HUMAN; IMMUNOLOGY; INCIDENCE; LEUKEMIA; LYMPHOCYTE COUNT; LYMPHOCYTE DEPLETION; MALE; METHODOLOGY; REGRESSION ANALYSIS; SEROLOGY; T LYMPHOCYTE;

ADULT; ALLELES; BONE MARROW TRANSPLANTATION; FEMALE; GRAFT VS HOST DISEASE; HISTOCOMPATIBILITY TESTING; HLA-DQ ANTIGENS; HLA-DR ANTIGENS; HUMANS; INCIDENCE; LEUKEMIA; LYMPHOCYTE COUNT; LYMPHOCYTE DEPLETION; MALE; REGRESSION ANALYSIS; SEROLOGY; T-LYMPHOCYTES; TISSUE DONORS;

EID: 0031160439     PISSN: 10838791     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (57)

1. Stroncek D, Bartsch G, Perkins HA, Randall BL, Hansen JA, McCullough J: The National Marrow Donor Program. Transfusion 33:567, 1993.
2. Marks DI, Cullis JO, Ward KN, Lacey S, Szydlo R, Hughes TP, Schwarer AP, Lutz E, Barrett AJ, Hows JM, Batchelor JR, Goldman JM: Allogeneic bone marrow transplantation for chronic myeloid leukemia using sibling and volunteer unrelated donors: A comparison of complications in the first 2 years. Ann Intern Med 119:207, 1993.
3. Chao NJ, Schmidt GM, Niland JC, Amylon MD, Dagis AC, Long GD, Nademanee AP, Negrin RS, O'Donnell MR, Parker PM, Smith EP, Snyder DS, Stein AS, Wong RM, Blume KG, Forman SJ: Cyclosporine, methotrexate, and prednisone compared with cyclosporine and prednisone for prophylaxis of acute graft-vs.-host disease. N Engl J Med 329:1225, 1993.
4. Busca A, Anasetti C, Anderson G, Appelbaum FR, Buckner CD, Doney K, Martin PJ, Petersdorf E, Sanders JE, Hansen JA: Unrelated donor or autologous marrow transplantation for treatment of acute leukemia. Blood 83:3077, 1994.
5. Ash RC, Casper JT, Chitambar CR, Hansen R, Bunin N, Truitt RL, Lawton C, Murray K, Hunter J, Baxter-Lowe LA, Gottschall J, Oldham K, Anderson T, Camitta B, Menitove J: Successful allogeneic transplantation of T-cell-depleted bone marrow from closely HLA-matched unrelated donors. N Engl J Med 322:485, 1990.
6. McGlave P, Bartsch G, Anasetti C, Ash C, Beatty PG, Gajewski J, Kernan NA: Unrelated donor marrow transplantation therapy for chronic myelogenous leukemia: Initial experience of the National Marrow Donor Program. Blood 81:543, 1993.
7. Beatty PG, Hansen JA, Longton GM, Thomas ED, Sanders JE, Martin PJ, Bearman SI, Anasetti C, Petersdorf EW, Mickelson EM, Pepe MS, Appelbaum FR, Buckner CD, Clift RA, Petersen FB, Stewart PS, Storb RF, Sullivan KM, Tesler MC, Witherspoon RP: Marrow transplantation from HLA-matched unrelated donors for treatment of hematologic malignancies. Transplantation 51:443, 1991.
8. Kernan NA, Bartsch G, Ash RC, Beatty PG, Champlin R, Filipovich A, Gajewski J, Hansen JA, Henslee-Downey J, McCullough J, McGlave P, Perkins HA, Phillips GL, Sanders J, Stroncek D, Thomas ED, Blume KG: Analysis of 462 transplantations from unrelated donors facilitated by the National Marrow Donor Program. N Engl J Med 328:593, 1993.
9. Gajewski JL, Ho WG, Feig SA, Hunt L, Kaufman N, Champlin RE: Bone marrow transplantation using unrelated donors for patients with advanced leukemia or bone marrow failure. Transplantation 50:244, 1990.
10. Anasetti C, Beatty PG, Storb R, Martin PJ, Mori M, Sanders JE, Thomas ED, Hansen JA: Effect of HLA incompability on graft-vs.-host disease, relapse, and survival after marrow transplantation for patients with leukemia or lymphoma. Hum Immunol 29:79, 1990.
11. Horowitz MM, Gale RP, Sondel PM, Goldman JM, Kersey J, Kolb H-J, Rimm AA, Ringden O, Rozman C, Speck B, Truitt RL, Zwaan FE, Bortin MM: Graft-vs.-leukemia reactions after bone marrow transplantation. Blood 75:555, 1990.
12. Martin PJ: Increased disparity for minor histocompatibility antigens as a potential cause of increased GVHD risk in marrow transplantation from unrelated donors compared with related donors. Bone Marrow Transplant 8:217, 1991.
13. Terasaki P, McClelland J: Microdroplet assay of human serum cytotoxins. Nature 204: 998, 1964.
14. Petersdorf EW, Smith AG, Mickelson EM, Martin PJ, Hansen JA: Ten HLA-DR4 alleles defined by sequence polymorphisms within the DRβ1 first domain. Immunogenetics 33:267, 1991.
15. Santamaria P, Reinsmoen NL, Lindstrom AL, Boyce-Jacino MT, Barbosa JJ, Faras AJ, McGlave PB, Rich SS: Frequent HLA class I and DP sequence mismatches in serologically (HLA-A, HLA-B, HLA-DR) and molecularly (HLA-DRB1, HLA-DQA1, HLA-DQB1) HLA-identical unrelated bone marrow transplant pairs. Blood 83:280, 1994.
16. Sengar DPS, Terasaki P: A semi-micro mixed leucocyte culture test. Transplantation 11:260, 1971.
17. Petersdorf EW, Stanley JF, Martin PJ, Hansen JA: Molecular diversity of the HLA-C locus in unrelated marrow transplantation. Tissue Antigens 44:93, 1994.
18. Bjorkman PJ, Saper MA, Samraoui B, Bennett WS, Strominger JL, Wiley DC: Structure of the human class I histocompatibility antigen, HLA-A2. Nature 329:506, 1987.
19. Brown JH, Jardetzky TS, Gorga JC, Stern LJ, Urban RG, Strominger JL, Wiley DC: Three-dimensional structure of the human class II histocompatibility antigen HLA-DR1. Nature 364:33, 1993.
20. Towsdale J, Young JA, Kelly AP, Austin PJ, Carson S, Meunier H, So A, Erlich HA, Spielman RS, Bodmer J, Bodmer WF: Structure, sequence, and polymorphism in the HLA-D region. Immunol Rev 85:5, 1985.
21. Scharf SJ, Griffith RL, Erlich HA: Rapid typing of DNA sequence polymorphism at the HLA-DRB1 locus using the polymerase chain reaction and nonradioactive oligonucleotide probes. Hum Immunol 30:190, 1991.
22. Yoshida M, Kimura A, Numano F, Saszuki T: Polymerase-chain-reaction-based analysis of polymorphism in the HLA-B gene. Hum Immunol 43:257, 1992.
23. Maeda M, Murayama N, Ishii H, Uryu N, Ota M, Tsuji K, Inoko H: A simple and rapid method for HLA-DQA1 genotyping by digestion of PCR-amplified DNA with allele specific restriction endonucleases. Tissue Antigens 34:290, 1989.
24. Jordan F, McWhinnie AJ, Turner S, Gavira N, Calvert AA, Cleaver SA, Holman RH, Goldman JM, Madrigal JA: Comparison of HLA-DRB1 typing by DNA-RFLP, PCR-SSO, and PCR-SSP methods and their application in providing matched unrelated donors for bone marrow transplantation. Tissue Antigens 45:103, 1995.
25. Ng J, Hurley CK, Baxter-Lowe LA, Chopek M, Coppo PA, Hegland J, KuKuruga D, Monos D, Rosner G, Schneckpeper B, Yang SY, Dupont B, Hartzmann RJ: Large-scale oligonucleotide typing for HLA-DRB1/3/4 and HLA-DQB1 is highly accurate, specific, and reliable. Tissue Antigens 42:473, 1993.
26. Bodmer JG, Marsh SGE, Albert ED, Bodmer WF, Bontrop RE, Charron D, Dupont B, Ehrlich H/a, Mach B, Mayr WR, Parham P, Saszuki T, Schreuder G, Strominger JL, Svejjarrd A, Terasaki P: Nomenclature for factors of the HLA system, 1995. Hum Immunol 43:149, 1995.
27. Kantarjian H, O'Brien S, Anderlini P, Talpaz M: Treatment of chronic myelogenous leukemia: Current status and investigation options. Blood 87:3069, 1996.
28. Nash RA, Pepe MS, Storb R, Longton G, Pettinger M, Anasetti C, Appelbaum FR, Bowden RA, Deeg HJ, Doney K, Martin PJ, Sullivan KM, Sanders J, Witherspoon RP: Acute graft-vs.-host disease: Analysis of risk factors after allogeneic marrow transplantation and prophylaxis with cyclosporine and methotrexate. Blood 80:1838, 1992.
29. Gajewski J, Lomen P, Feig S, Gravas A, Champlin R: Anti-CD5-ricin A chain immunotoxin for prevention of acute graft-vs.-host disease in closely HLA-matched unrelated donor bone marrow transplants. Exp Hematol 18:712a, 1990 (abstr 620).
30. Przepiorka D, Gajewski J, Ippoliti C, Khouri I, Williams P, Giralt S, Mehra R, Nimer S, van Besien K, Territo M, Deisseroth AB, Champlin R: The combination of partial T-cell depletion and immunotoxin is optimal GVHD prophylaxis after MUD BMT. Proc First Ann Mtg ASBMT:p77, 1995 (abstr 114).
31. Gajewski J, Przepiorka D, Giralt S, Thorny M, Moseley A, Lloyd K, Huynh L, Thandi D, Marshall M, Rondon G, Korbling M, Andersson B, Nellis K, Deisseroth A, van Besian K, Mehra R, Ippoliti C, Warkintin D, Okarma T, Greene S, von Wolff B, Chan K, Lebkowski J, Champlin R: Effective partial depletion of T-cells by panning using anti-CD5/8 antibody coated flasks in HLA-mismatched bone marrow transplants. Blood 84:542a, 1994 (abstr 2155).
32. Park MS, Tonai R: Phenotype frequencies of the Class II (DR, DQ) DNA alleles by the patterns of sequence specific primer mixtures (SSPM) in four different populations and the probable haplotypes between DRβ1 allele and DQβ allele. In: PI Terasaki and JM Cecka (eds): Clinical Transplants. 1992. Los Angeles, UCLA Tissue Typing Laboratory, 475, 1993.
33. Tonai R, Terasaki P: DNA typing of HLA-DR by sequence specific primers. In: American Society for Histocompatibility and Immunogenetics Manual, 3rd Edition. Lenexa, IV.C.4.1, 1994.
34. Kaplan E, Meier P: Non parametric estimation for incomplete observation. J Am Stat Assoc 53:457, 1958.
35. Cox D: Regression models and life-tables. J R Stat Soc (B) 34:187, 1972.
36. Weisdorf D, Haake R, Blazar B, Miller W, McGlave P, Ramsay N, Kersey J, Filopovich A: Treatment of moderate/severe acute graft-vs.-host disease after allogeneic bone marrow transplantation: Analysis of clinical risk features and outcome. Blood 75:1024, 1990.
37. Gajewski J, Petz L, Calboun L, O'Rourke S, Landaw E, Lyddane N, Hunt L, Schiller G, Ho W, Champlin R: Hemolysis of transfused group O red blood cells in minor ABO-incompatible unrelated-donor bone marrow transplants in patients receiving cyclosporine without posttransplant methotrexate. Blood 79:3076, 1992.
38. Glucksberg H, Storb R, Fefer A, Buckner CD, Neiman PE, Clift RA, Lerner KG, Thomas ED: Clinical manifestations of graft-vs.-host disease in human recipients of marrow from HLA-matched sibling donors. Transplantation 18:295, 1974.
39. Prezepiorka D, Weisdorf D, Martin P, Klingemann H, Beatty P, Hows J, Thomas ED: Consensus conference on acute GVHD grading. Bone Marrow Transplant 15:825, 1995 (Meeting report).
40. Beatty PG, Anasetti C, Hansen JA, Longton GM, Sanders JE, Martin PJ, Mickelson EM, Choo SK, Petersdorf EW, Pepe MS, Appelbaum FR, Bearman SI, Buckner CD, Clift RA, Petersen FB, Singer J, Stewart PS, Storb RS, Sullivan KM, Tesler MC, Witherspoon RP, Thomas ED: Marrow transplantation from unrelated donors for treatment of hematologic malignancies: Effect of mis-matching for one HLA locus. Blood 81:249, 1993.
41. Davies SM, Shu XO, Blazar BR, Filipovich AH, Kersey JH, Krivit W, McCullough J, Miller WJ, Ramsay RKC, Segall M, Wagner JE, Weisdorf DJ, McGlave PB: Unrelated donor bone marrow transplantation: Influence of HLA A and B incompatibility on outcome. Blood 86:1636, 1995.
42. Kato Y, Mitsuishi Y, Cecka M, Hopfield J, Hunt L, Champlin R, Terasaki PI, Gajewski JL: HLA-DP incompatibilities and severe graft-vs.-host disease in unrelated bone marrow transplants. Transplantation 52:374, 1991.
43. Petersdorf EW, Smith AG, Mickelson EM, Longton GM, Anasetti C, Choo SY, Martin PJ, Hansen JA: The role of HLA-DPB1 disparity in the development of acute graft-vs.-host disease following unrelated donor marrow transplantation. Blood 81:1923, 1993.
44. Nademanee A, Schmidt GM, Parker P, Dagis AC, Stein A, Snyder DS, O'Donnell M, Smith EP, Stepan DE, Molina A, Wong KK, Margolin K, Somlo G, Littrell B, Woo D, Sniecinski I, Niland JC, Forman SJ: The outcome of matched unrelated donor bone marrow transplantation in patients with hematologic malignancies using molecular typing for donor selection and graft-vs.-host disease prophylaxis regimen of cyclosporine, methotrexate, and prednisone. Blood 86:1228, 1995.
45. Petersdorf EW, Longton GM, Anasetti C, Martin PJ, Mickelson EM, Smith AG, Hansen JA: The significance of HLA-DRB1 matching on clinical outcome after HLA-A, B, DR identical unrelated donor marrow transplantation. Blood 86:1606, 1995.
46. Speiser DE, Tiercy JM, Rufer N, Grundschober C, Gratwohl A, Chapius B, Heig C, Löliger C, Siren M-K, Roosnek E, Jeannet M: High resolution HLA matching associated with decreased mortality after unrelated bone marrow transplantation. Blood 87:4455, 1996.
47. Mitsuyasu R, Champlin RE, Gale RP, Ho WG, Lenarsky C, Winston D, Selch M, Elashoff R, Giorgi JV, Wells J, Terasaki P, Billing R, Feig S: Treatment of donor bone marrow with monoclonal anti-T-cell antibody and complement for prevention of acute graft-vs.-host disease. A prospective, randomized, double-blind trial. Ann Intern Med 105:20, 1986.
48. Horowitz M, Klein J, Zhang M, Szydlo R, Goldman J: Who is the best bone marrow donor? A comparison of HLA mismatched related and unrelated donor transplants for leukemia. Blood 84:393a, 1994 (abstr 1556).
49. Aversa F, Tabilio A, Terenzi A, Velardi A, Falzetti F, Giannon C, Iacucci R, Zei T, Martelli MP, Gambelunghe I, Rossetti M, Caputo P, Latini P, Aristei C, Raymondi C, Reisner Y, Martelli MF: Successful engraftment of T-cell depleted haploidentical "three loci" incompatible transplants in leukemia patients by addition of recombinant granulocyte colony-stimulating factor mobilized peripheral blood progenitors cells to bone marrow inoculum. Blood 84:3948, 1994.
50. Fernandez-Vina M, Lazaro AM, Sun Y, Miller S, Forero L, Stastny P: Population diversity of B locus alleles observed by high resolution DNA typing. Tissue Antigen 45:153, 1995.
51. Degli-Esposti MA, Leaver AL, Christiansen FT, Witt CS, Abraham LJ, Dawkins RL: Ancestral haplotypes: Conserved population MHC haplotypes. Hum Immunol 34:242, 1992.
52. Alper C, Awdeh Z, Yunis E: Complotypes, extended haplotypes, male segregation distortion and disease markers. Human Immunol 15: 366, 1986.
53. Shaw S, Duquesnoy R, Smith P: Population studies of the HLA-linked SB antigens. Immunogenetics 14:153, 1981.
54. Fleischhauer K, Kernan N, O'Reilly RJ, Dupont B, Yang S: Bone marrow-allograft rejection by T-lymphocytes recognizing a single amino acid difference in HLA-B44. N Engl J Med 323:1818, 1990.
55. Petersdorf E, Longton G, Anasetti C, Smith A, McKinney S, Martin P, Hansen J: Donor-recipient disparity for HLA-C genes is a risk factor for graft failure following marrow transplantation from unrelated donors. Blood 86:291a, 1995 (abstr 1151).
56. Golumy E, Schipper R, Pool J, Blokland E, Frederik JH, Falkenburg J, Vossen J, Gratwohl A, Vogelsang GB, van Houwelingen HC, van Rood JJ: Mismatches of minor histocompatibility antigens between HLA-identical donors and recipients and the development of graft-vs.-host disease after bone marrow transplantation. N Engl J Med 334:281, 1996.
57. Behar E, Chao JN, Hiraki DD, Krishnaswamy S, Brown BW, Zehnder JL, Grumet FC: Polymorphism of adhesion molecule CD31 and its role in acute graft-vs.-host disease. New Eng J Med 334:286, 1996.